23-July-2021
Meet our newest Akcesoian!
Károly Dénes has joined our team in February 2021. He has extensive knowledge and experience in the area of nonlinear dynamics, physics and computer modelling. Not long after joining the company, Karoly has earned his PhD in Physics at Babeș-Bolyai University of Cluj-Napoca, Romania. We are very proud of his achievement and we are confident that he will be able to maintain and further develop the company’s suite of Market Access and Pricing tools.
Welcome on board Kari! 🎊
Read the recent posts in our blog
April 2nd Tariffs Proclamation Increases Pressure on US Pharma Imports
On April 2, 2026, President Trump imposed 100% tariffs under Section 232 on patented pharmaceuticals and APIs. Exemptions for generics, MFN agreements, and onshoring. Impact on US imports analysed.
Faces Behind the Tools: Dávid and Szabolcs, Akceso’s Newest Techie Pillars for IRP and MFN Excellence
We are happy to introduce Dávid and Szabolcs, the two newest members of our Techie team, both joined recently in 2025.
Akceso Advisors elects Dr. Seng Chin Mah as Board Member
Akceso Advisors AG, a leading independent global advisory firm specializing in market access, pricing, reimbursement strategy, operations and policy-setting for life-science companies and authorities, announced today the election of Dr. Seng Chin Mah as a new non‑executive member of its Board of Directors.
Mind the communication gap in patient access
Read the story of how the clear communication unlocked the market access potential of an innovative product for our client.
